USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!Not a subscriber?
Learn more!
Bendroflumethiazide
C15H14F3N3O4S2 421.41
 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide, (±)-;
 (±)-3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide [73-48-3]

BRIEFING

 Bendroflumethiazide. This proposal is based on the version of the monograph official December 1, 2021. It is proposed to omit this monograph for the following reasons:

  1. No drug products formulated with Bendroflumethiazide are currently marketed in the United States.

  2. Drug products containing Bendroflumethiazide are currently not used in veterinary medicine in the United States.

 (SM6: L. Ahmad)

 Case ID—SUB-1850

USP REFERENCE STANDARDS FOR PURCHASE

USP 2,4-Disulfamyl-5-trifluoromethylaniline RS
USP Bendroflumethiazide RS
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!Not a subscriber?
Learn more!